Author

A. Cabezas-Cruz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:plant (other)· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

J. de la Fuente· 2 shared A. Estrada-Pena· 1 shared A. Farce· 1 shared A. Hodzic· 1 shared A. Wu-Chuang· 1 shared C. Gortazar· 1 shared C. M. Cabrera· 1 shared D. Obregon· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. de la Fuente

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Characterization of GEXP15 as a potential regulator of Protein Phosphatase 1 and partner of ribosomal complex in Plasmodium falciparum.

H. Mansour, A. Cabezas-Cruz, V. Peucelle, A. Farce, S. Salome-Desnoulez, I. Metatla, I. C. Guerrera, T. Hollin, J. Khalife

This study identifies GEXP15 as a regulator of PP1 and ribosomal complex in Plasmodium falciparum, enhancing PP1 phosphatase activity and suggesting it as a drug target.

bioRxiv · Jul 4, 2023 · PreprintMicrobiology

Anti-microbiota vaccines modulate the tick microbiome in a taxon-specific manner

L. Mateos-Hernandez, D. Obregon, A. Wu-Chuang, J. Maye, J. Borneres, N. Versille, J. de la Fuente, S. Diaz, L. Bermudez-Humaran, E. Torres-Maravilla, A. Estrada-Pena, A. Hodzic, L. Simo, A. Cabezas-Cruz

This study shows that anti-tick microbiota vaccines specifically alter the tick microbiome, with effects dependent on the targeted bacterial taxon.

bioRxiv · May 12, 2021Immunology

The antibody response to the glycan α-Gal correlates with COVID-19 disease symptoms

J. M. Urra, E. Ferreras-Colino, M. Contreras, C. M. Cabrera, I. G. Fernandez de Mera, M. Villar, A. Cabezas-Cruz, C. Gortazar, J. de la Fuente

This study examines the correlation between anti-α-Gal antibody levels and COVID-19 disease severity in patients compared to healthy controls.

bioRxiv · Jul 14, 2020Immunology